The USA compounding pharmacy market in the United States is on track for significant expansion, with a projected valuation of US$ 23,430.35 million by 2033. This surge represents a robust Compound Annual Growth Rate (CAGR) of 7.8% anticipated between 2023 and 2033. The market’s current value is estimated to be US$ 11,099.0 million in 2023. …